Bridging the gender gap in atrial fibrillation

Expert Review of Cardiovascular Therapy

Volumn 13, Issue 3, 2015, Pages 317-323

  Oza, Nishaki Mehta ^a   Baveja, Swati ^b   Tedrow, Usha ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b SAINT VINCENT HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

atrial fibrillation; gender; management; outcomes; pathophysiology

Indexed keywords

ANTIARRHYTHMIC AGENT; ESTROGEN; PROGESTERONE; TESTOSTERONE; ANTICOAGULANT AGENT;

AGE; ANTICOAGULATION; CARDIOVASCULAR RISK; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; LUTEAL PHASE; NON VALVULAR ATRIAL FIBRILLATION; NONHUMAN; P WAVE; PATHOPHYSIOLOGY; QT INTERVAL; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SURVIVAL; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; ANIMAL; ATRIAL FIBRILLATION; CATHETER ABLATION; CHEMICALLY INDUCED; COMPLICATION; FEMALE; HEALTH CARE DISPARITY; HEMORRHAGE; MALE; PREVALENCE; RISK; STATISTICS AND NUMERICAL DATA; STROKE; THROMBOEMBOLISM;

ANIMALS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HEALTHCARE DISPARITIES; HEMORRHAGE; HUMANS; MALE; PREVALENCE; RISK; SEX FACTORS; STROKE; THROMBOEMBOLISM;

EID: 84923274780     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.1002466     Document Type: Review

References (77)

1. Heeringa J. Atrial fibrillation: is the prevalence rising? Europace 2010;12(4): 451-2
2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114(2):119-25
3. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death the Framingham Heart Study. Circulation 1998;98(10):946-52
4. Coyne KS, Paramore C, Grandy S, et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006;9(5):348-56
5. Wu EQ, Birnbaum HG, Mareva M, et al. Economic burden and comorbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin 2005; 21(10):1693-9
6. Stein JH, Hadigan CM, Brown TT, et al. Prevention strategies for cardiovascular disease in HIV-infected patients. Circulation 2008;118(2):e54-60
7. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation 2010;121(7):948
8. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics- 2010 update. a report from the American heart association. Circulation 2009;121(7): e46-215
9. Humphries KH, Kerr CR, Connolly SJ, et al. New-onset atrial fibrillation sex differences in presentation, treatment, and outcome. Circulation 2001;103(19):2365-70
10. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995;155(5):469-73
11. Pittrow D, Beltzer A, Kruck I, et al. Gender differences in patients with atrial fibrillation. Herzschrittmacherther Elektrophysiol 2013; 24(3):176-83
12. Liu K, Ballew C, Jacobs D, et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. the cardia study. Hypertension 1989;14(2): 218-26
13. Burke JH, Goldberger JJ, Ehlert FA, et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med 1996; 100(5):537-43
14. Rosano GM, Leonardo F, Rosano G, et al. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 1996;347(9004):786-8
15. Ball J, Carrington MJ, Wood KA, et al. Women versus men with chronic atrial fibrillation: insights from the standard versus atrial fibrillation specific management study (Safety). PloS One 2013;8(5):e65795
16. Potpara TS, Marinkovic JM, Polovina MM, et al. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int J Cardiol 2012;161(1):39-44
17. Dagres N, Nieuwlaat R, Vardas PE, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the euro heart survey on atrial fibrillation. J Am Coll Cardiol 2007;49(5):572-7
18. Conen D, Tedrow UB, Koplan BA, et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009; 119(16):2146-52
19. Conen D, Tedrow UB, Cook NR, et al. Alcohol consumption and risk of incident atrial fibrillation in women. JAMA 2008; 300(21):2489-96
20. Tedrow UB, Conen D, Ridker PM, et al. The long-and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women's Health Study). J Am Coll Cardiol 2010;55(21): 2319-27
21. Maganti K, Rigolin V, Bonow R. Valvular heart disease in women. Curr Cardio Risk Rep 2008;2(3):217-26
22. Quintana-Gallego E, Carmona-Bernal C, Capote F, et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir Med 2004; 98(10):984-9
23. Bhardwaj R, Sharma P, Finkel MS, et al. Gender and geographic differences in CAD risk factors and CHADS2 scores in atrial fibrillation patients. W V Med J 2012; 108(1):18-21
24. Senoo K, Lane D, Lip GY. Stroke and bleeding risk in a trial fibrillation. Korean Circ J 2014;44(5):281-90
25. Chapa DW, Akintade B, Schron E, et al. Is health-related quality of life a predictor of hospitalization or mortality among women or men with atrial fibrillation? J Cardiovasc Nurs 2013
26. Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the rate control versus electrical cardioversion (RACE) Study. J Am Coll Cardiol 2005;46(7): 1298-306
27. Whang W, Davidson KW, Conen D, et al. Global psychological distress and risk of atrial fibrillation among women: the women's health study. J Am Heart Assoc 2012;1(3):e001107
28. Tsadok MA, Jackevicius CA, Rahme E, et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 2012;307(18):1952-8
29. Friberg L, Benson L, Rosenqvist M, et al. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 2012;344: e3522
30. Inoue H, Atarashi H, Okumura K, et al. Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation. Am J Cardiol 2014;113(6):957-62
31. Wagstaff AJ, Overvad TF, Lip GY, et al. Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. QJM 2014;107(12):955-67
32. European Heart Rhythm Association, Camm AJ, Kirchhof P, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC). Eur Heart J 2010;31(19): 2369-429
33. Conen D, Ridker PM, Everett BM, et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J 2010;31(14):1730-6
34. Patton KK, Heckbert SR, Alonso A, et al. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity. Heart 2013;99(24):1832-6
35. Mohanty S, Mohanty P, Di Biase L, et al. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation. J Cardiovasc Electrophysiol 2011;22(8): 858-65
36. Zado E. Gender differences in prevalence and distribution of provocable non-pulmonary vein triggers found during atrial fibrillation ablation. In: HRS meeting name heart rhythm on demand. 2014
37. Rangadham Nagarakanti M. Impact of gender in mapping of atrial tachyarrhythmias (Rotors) during biatrial and 3-dimensional non-contact mapping of spontaneous atrial fibrillation in humans. In: HRS Meeting Name Heart Rhythm On Demand. 2014
38. Joseph Hadaya B. Sex specific differences in gene expression in human left atrial tissue. In: HRS Meeting Name Heart Rhythm On Demand. 2014
39. Pfannmüller B, Boldt A, Reutemann A, et al. Gender-specific remodeling in atrial fibrillation? Thorac Cardiovasc Surg 2013; 61(01):66-73
40. Wilhelm M, Roten L, Tanner H, et al. Gender differences of atrial and ventricular remodeling and autonomic tone in nonelite athletes. Am J Cardiol 2011;108(10): 1489-95
41. Karabag T, Hanci V, Aydin M, et al. Influence of menstrual cycle on P wave dispersion. Int Heart J 2011;52(1):23-6
42. Burke JH, Ehlert FA, Kruse JT, et al. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997;79(2):178-81
43. Shufelt CL, Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 2009;53(3):221-31
44. Bai CX, Kurokawa J, Tamagawa M, et al. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 2005;112(12):1701-10
45. Bidoggia H, Maciel JP, Capalozza N, et al. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am Heart J 2000; 140(4):678-83
46. Toivonen L, Helenius K, Viitasalo M. Electrocardiographic repolarization during stress from awakening on alarm call. J Am Coll Cardiol 1997;30(3):774-9
47. Nakagawa M, Sekine Y, Ono M, et al. Gender differences in the effect of auditory stimuli on ventricular repolarization in healthy subjects. J Cardiovasc Electrophysiol 2009;20(6):653-7
48. Stoney CM, Matthews KA, McDonald RH, et al. Sex differences in lipid, lipoprotein, cardiovascular, and neuroendocrine responses to acute stress. Psychophysiology 1988;25(6):645-56
49. Lampert R. Use of antiarrhythmic medications in women. European Cardiology 2010;6:70-3
50. Pengo V, Legnani C, Noventa F, et al. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. a multicenter inception cohort study. Thromb Haemost 2001;85(3):418-22
51. Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2005;112(12):1687-91
52. Gomberg-Maitland M, Wenger NK, Feyzi J, et al. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J 2006;27(16): 1947-53
53. Rochat MC, Waeber G, Wasserfallen JB, et al. Hospitalized women experiencing an episode of excessive oral anticoagulation had a higher bleeding risk than men. J Womens Health (Larchmt) 2009;18(3):321-6
54. Lip GY, Eikelboom J, Yusuf S, et al. Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation a secondary analysis of the averroes study. Stroke 2014;45(7):2127-30
55. Desai NR, Krumme AA, Schneeweiss S, et al. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation-quality and cost implications. Am J Med 2014;127(11):1075-82
56. Stangier J, Stahle H, Rathgen K, et al. Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects. Clin Pharmacokinet 2008;47(1):47-59
57. Manning JA. Outpatient management of oral anticoagulation in atrial fibrillation. Crit Care Nurs Clin North Am 2013;25(4): 481-7
58. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014;383(9921):955-62
59. John Camm A, Colombo A, Corbucci G, et al. Left atrial appendage closure: a new technique for clinical practice. Heart Rhythm 2014;11(3):514-21
60. Onalan O, Crystal E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 2007;38(2):624-30
61. Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation data of the Rate Control versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 2005;46(7): 1298-306
62. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270(21): 2590-7
63. Lehmann MH, Hardy S, Archibald D, et al. Sex difference in risk of torsade de pointes with d, l-sotalol. Circulation 1996;94(10): 2535-41
64. Roten L, Rimoldi SF, Schwick N, et al. Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing Clin Electrophysiol 2009; 32(5):622-6
65. Hara M, Danilo P, Rosen MR. Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J Pharmacol Exp Ther 1998;285(3): 1068-72
66. Patel D, Armaganijan LV, Morillo CA. Atrial fibrillation catheter ablation in females: same hardware, different findings. Expert Rev Cardiovasc Ther 2011;9(11): 1391-5
67. Prashant Bhave M. Race and gender disparities in electrophysiology subspecialty care in patients diagnosed with atrial fibrillation. In: Heart Rhythm On Demand 2014
68. Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 2007;9(8):613-20
69. Patel D, Mohanty P, Di Biase L, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010;7(2):167-72
70. Zhang XD, Tan HW, Gu J, et al. Efficacy and safety of catheter ablation for longstanding persistent atrial fibrillation in women. Pacing Clin Electrophysiol 2013; 36(10):1236-44
71. Tanner H, Makowski K, Roten L, et al. Catheter ablation of atrial fibrillation as first-line therapy-a single-centre experience. Europace 2011;13(5):646-53
72. Gill JS. How to perform pulmonary vein isolation. Europace 2004;6(2):83-91
73. Takigawa M, Kuwahara T, Takahashi A, et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int J Cardiol 2013;168(3): 1984-91
74. Henry L, Hunt S, Holmes SD, et al. Are there gender differences in outcomes after the cox-maze procedure for atrial fibrillation? Innovations (Phila) 2013;8(3): 190-8
75. Birgitta Johansson M. Higher rate of arrythmia recurrence but not of all-cause mortality in women than in men after cut-and-sew maze surgery for atrial fibrillation. Heart Rhythm 2014;11(5)
76. Michowitz Y, Rahkovich M, Oral H, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol 2014;7(2):274-80
77. Shin JS, Tahk SJ, Yang HM, et al. Impact of female gender on bleeding complications after transradial coronary intervention (from the Korean Transradial Coronary Intervention Registry). Am J Cardiol 2014; 113(12):2002-6